Wei Lin Selected Research

Tretinoin (Retinoic Acid)

11/2023	Homoharringtonine-Based Induction Regimen Improved the Remission Rate and Survival Rate in Chinese Childhood AML: A Report From the CCLG-AML 2015 Protocol Study.
1/2020	A Systematic Analysis Revealed the Potential Gene Regulatory Processes of ATRA-Triggered Neuroblastoma Differentiation and Identified a Novel RA Response Sequence in the NTRK2 Gene.
10/2019	Long-term follow-up of children with acute promyelocytic leukemia treated with Beijing Children's Hospital APL 2005 protocol (BCH-APL 2005).
8/2008	[Effect of additional chromosome abnormalities on the outcome of newly diagnosed acute promyelocytic leukemia treated with red arsenic sulfide and all trans-retinoic acid plus anthracyclin based protocol].
7/2006	Cell aggregation-induced FGF8 elevation is essential for P19 cell neural differentiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei Lin Research Topics

Disease

131	Neoplasms (Cancer) 05/2024 - 08/2003
33	Inflammation (Inflammations) 01/2024 - 03/2012
22	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 07/2003
20	Glioma (Gliomas) 01/2024 - 01/2009
18	Infections 04/2024 - 09/2007
18	Neoplasm Metastasis (Metastasis) 07/2023 - 12/2006
17	Carcinogenesis 04/2024 - 01/2009
17	Wounds and Injuries (Trauma) 03/2024 - 09/2007
14	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 04/2024 - 03/2009
14	Carcinoma (Carcinomatosis) 04/2024 - 07/2006
13	Pain (Aches) 04/2024 - 10/2016
12	Stomach Neoplasms (Stomach Cancer) 03/2024 - 06/2006
12	Brain Injuries (Brain Injury) 11/2023 - 10/2013
12	Hypoxia (Hypoxemia) 11/2023 - 07/2013
12	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 09/2009
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 11/2017
10	Breast Neoplasms (Breast Cancer) 01/2024 - 11/2013
10	Hypertension (High Blood Pressure) 01/2024 - 01/2013
10	Type 2 Diabetes Mellitus (MODY) 01/2023 - 10/2012
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 05/2005
9	Hemorrhage 04/2024 - 01/2013
9	Glioblastoma (Glioblastoma Multiforme) 12/2023 - 11/2009
9	Fibrosis (Cirrhosis) 09/2023 - 04/2013
9	Obesity 01/2023 - 10/2012
9	Immunoglobulin G4-Related Disease 01/2021 - 05/2014
8	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2023 - 05/2005
8	Ischemia 11/2023 - 01/2018
8	COVID-19 01/2023 - 11/2020
8	Leukemia 11/2022 - 08/2003
8	Parkinson Disease (Parkinson's Disease) 11/2022 - 10/2011
8	Melanoma (Melanoma, Malignant) 01/2022 - 07/2005
8	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 06/2006
7	Diabetes Mellitus 10/2023 - 01/2011
7	Osteoarthritis 10/2023 - 11/2006
6	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2024 - 01/2022
6	Vasculitis (Vasculitides) 04/2024 - 03/2009
6	Reperfusion Injury 01/2024 - 02/2015
6	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 01/2017
6	Osteoporosis 12/2023 - 01/2005
6	Proteinuria 11/2023 - 01/2013
6	Insulin Resistance 11/2021 - 06/2014
5	Acute Kidney Injury (Acute Renal Failure) 04/2024 - 09/2017
5	Lung Neoplasms (Lung Cancer) 11/2023 - 12/2013
5	Hypersensitivity (Allergy) 01/2023 - 12/2015
5	Disease Progression 01/2023 - 12/2018
4	Chronic Renal Insufficiency 04/2024 - 01/2021

Drug/Important Bio-Agent (IBA)

62	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2005
32	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2011
20	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2015
20	Messenger RNA (mRNA)IBA 04/2023 - 08/2003
14	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2024 - 03/2009
13	CytokinesIBA 04/2024 - 02/2013
13	MicroRNAs (MicroRNA)IBA 01/2022 - 04/2011
12	Peroxidase (Myeloperoxidase)IBA 04/2024 - 03/2009
12	Long Noncoding RNAIBA 09/2023 - 01/2017
11	Immunoglobulin G (IgG)IBA 11/2023 - 07/2009
10	RNA (Ribonucleic Acid)IBA 03/2024 - 12/2006
10	Therapeutic UsesIBA 01/2024 - 05/2005
10	Small Interfering RNA (siRNA)IBA 08/2023 - 12/2006
10	EnzymesIBA 07/2023 - 04/2013
10	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 01/2012
10	VaccinesIBA 01/2022 - 01/2017
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017 - 12/2006
9	pien tze huangIBA 04/2024 - 05/2012
9	Indicators and Reagents (Reagents)IBA 03/2024 - 06/2009
9	Oxygen (Dioxygen)IBA 11/2023 - 01/2011
8	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 03/2014
8	CollagenIBA 12/2023 - 12/2012
7	Neuroprotective AgentsIBA 08/2023 - 01/2012
6	CreatinineIBA 04/2024 - 03/2009
6	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 07/2003
6	Estrogens (Estrogen)FDA Link 02/2024 - 09/2009
6	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 07/2007
6	LipidsIBA 12/2023 - 01/2015
6	salicylhydroxamic acid (SHAM)IBA 10/2023 - 01/2019
6	Retinaldehyde (Retinal)IBA 09/2023 - 01/2011
6	AntibodiesIBA 01/2023 - 08/2008
6	GlucocorticoidsIBA 01/2022 - 10/2014
5	CholesterolIBA 12/2023 - 06/2014
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2023 - 07/2006
5	Temozolomide (Temodar)FDA LinkGeneric 10/2022 - 12/2016
5	LigandsIBA 06/2022 - 04/2011
5	Phosphotransferases (Kinase)IBA 04/2022 - 09/2009
5	CalciumIBA 04/2021 - 05/2009
5	NF-kappa B (NF-kB)IBA 01/2021 - 02/2013
5	Adenosine Triphosphate (ATP)IBA 01/2021 - 10/2013
5	Ethanol (Ethyl Alcohol)IBA 09/2017 - 03/2013
4	AlbuminsIBA 05/2024 - 10/2020
4	Mechanistic Target of Rapamycin Complex 1IBA 04/2024 - 10/2016

Therapy/Procedure

54	Therapeutics 04/2024 - 09/2007
22	Drug Therapy (Chemotherapy) 01/2024 - 01/2005
13	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 01/2013
9	Gastrectomy 03/2024 - 04/2019
7	Deep Brain Stimulation 09/2023 - 10/2020
6	Radiotherapy 12/2023 - 04/2016
5	Aftercare (After-Treatment) 04/2024 - 06/2017
5	Intraperitoneal Injections 11/2023 - 01/2005
5	Transplantation 07/2023 - 07/2007
5	Arthroplasty 03/2023 - 05/2021
5	Length of Stay 01/2023 - 09/2019